Revenue: The sum of all revenue fields included for a company's operating activities.
NKGen Biotech, Inc. (NKGN) Revenue data is not available for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$6.31M |
|
-- |
|
-- |
|
$6.79M |
|
$-6.79M |
|
$13.39M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$6.60M |
|
$-6.79M |
|
$-6.46M |
|
29.13M |
|
41.33M |
|
$0.23 |
|
$0.15 |
|
| Balance Sheet Financials | |
$0.91M |
|
$13.58M |
|
$14.08M |
|
$14.99M |
|
$37.12M |
|
$10.60M |
|
$24.93M |
|
$62.05M |
|
$-47.05M |
|
$-47.05M |
|
$-47.05M |
|
35.72M |
|
| Cash Flow Statement Financials | |
$-13.93M |
|
$0.00M |
|
$13.89M |
|
$0.28M |
|
$0.24M |
|
$-0.04M |
|
$3.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.29 |
|
-0.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.02% |
|
-14.02% |
|
44.00% |
|
-18.10% |
|
$-1.32 |
|
$-0.34 |
|
$-0.34 |
|